GCIA
ZBH icon

Gabelli & Co Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,751
Closed -$205K – 173
2017
Q4 		$205K Buy
+1,751
New +$198K 0.03% 146
2017
Q2 		– Sell
-2,060
Closed -$244K – 176
2017
Q1 		$244K Hold
2,060
– – 0.03% 134
2016
Q4 		$206K Buy
+2,060
New +$221K 0.02% 140

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gabelli & Co Investment Advisers's ZBH Position: Q1 2018 in Review

Gabelli & Co Investment Advisers sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 1,751 shares — an estimated $205K sold.

Gabelli & Co Investment Advisers first reported a position in ZBH in Q4 2016 and held it in 3 quarters. The position peaked at $244K in Q1 2017. 876 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • Gabelli & Co Investment Advisers reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 1,751 Zimmer Biomet shares in Q1 2018, an estimated $205K.
  • Gabelli & Co Investment Advisers first reported a position in Zimmer Biomet in Q4 2016 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's Zimmer Biomet position peaked at $244K in Q1 2017.
  • 876 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2018, filed 9 May 2018.